Background and purpose
Melatonin receptors have been extensively characterized regarding their affinity and pharmacology, mostly using 2-[(125)I]-melatonin as a radioligand. Although [(3)H]-melatonin has the advantage of corresponding to the endogenous ligand of the receptor, its binding has not been well described. Experimental approach: We characterized [(3)H]-melatonin binding to the hMT&sub1; and hMT&sub2; receptors expressed in a range of cell lines and obtained new insights into the molecular pharmacology of melatonin receptors. Key
Purpose
Melatonin receptors have been extensively characterized regarding their affinity and pharmacology, mostly using 2-[(125)I]-melatonin as a radioligand. Although [(3)H]-melatonin has the advantage of corresponding to the endogenous ligand of the receptor, its binding has not been well described. Experimental approach: We characterized [(3)H]-melatonin binding to the hMT&sub1; and hMT&sub2; receptors expressed in a range of cell lines and obtained new insights into the molecular pharmacology of melatonin receptors. Key
Results
The binding of [(3)H]-melatonin to the hMT&sub1; and hMT&sub2; receptors displayed two sites on the saturation curves. These two binding sites were observed on cell membranes expressing recombinant receptors from various species as well as on whole cells. Furthermore, our GTPγS/NaCl results suggest that these sites on the saturation curves correspond to the G-protein coupled and uncoupled states of the receptors, whose pharmacology was extensively characterized. Conclusions and implications: hMT&sub1; and hMT&sub2; receptors spontaneously exist in two states when expressed in cell lines; these states can be probed by [(3)H]-melatonin binding. Overall, our results suggest that physiological regulation of the melatonin receptors may result from complex and subtle mechanisms, a small difference in affinity between the active and inactive states of the receptor, and spontaneous coupling to G-proteins.